Repligen | Kortsiktig Gjeld



Current Liabilities Endring Dato
Agilent USD 1.87B 26M 2025-01
Align Technology USD 1.99B 47.08M 2025-03
Bio Techne USD 161.26M 19.13M 2024-12
BioMarin Pharmaceutical USD 606.99M 108.67M 2024-12
Bristol-Myers Squibb USD 24.07B 296M 2025-03
Bruker USD 1.28B 37.5M 2024-12
Charles River Laboratories USD 994.1M 18.12M 2024-12
Danaher USD 6.64B 153M 2025-03
Dentsply International USD 1.59B 47M 2024-12
Exact Sciences USD 732.19M 8.52M 2024-12
General Electric USD 34.94B 549M 2025-03
Henry Schein USD 2.8B 126M 2024-12
Illumina USD 1.55B 572M 2024-12
IQVIA Holdings USD 6.96B 35M 2024-12
Mettler Toledo International USD 1.17B 16.77M 2024-12
Myriad Genetics USD 164.1M 9.8M 2024-12
Pfizer USD 43B 216M 2024-12
Repligen USD 152M 25.21M 2025-03
Revvity USD 648.19M 4.91M 2025-03
Standard Biotools USD 65.89M 54.72M 2024-12
Thermo Fisher Scientific USD 13.17B 158M 2025-03
Waters USD 789.76M 26.28M 2024-12
West Pharmaceutical Services USD 526.7M 23.7M 2025-03



Repligen Kortsiktig Gjeld - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - May 2025.